Sigumir Protocol
Dosing & Research
Last Updated: April 22, 2026
Cardiovascular support research, Blood-pressure and vascular aging models, Microcirculation studies, Cardiac resilience
Half-Life
Variable (complex)
Administration
Oral
Frequency
1-2 times daily
How It Works
- Cardiovascular support research
- Blood-pressure and vascular aging models
- Microcirculation studies
- Cardiac resilience
Dosing Structure
Dose
20–40 mg
Frequency
1-2 times daily
Notes
Typically Administered As Defined Courses (10–20 Days) Repeated 1–2x Per Year
Example Protocols
Dose: 20–40 mg
Frequency: 1-2 times daily
Duration: 30 Days
Off Period: Not listed
Protocol Notes
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.